Zobrazeno 1 - 10
of 764
pro vyhledávání: '"Kosaryan, M."'
Publikováno v:
International Medical Case Reports Journal, Vol Volume 12, Pp 1-7 (2018)
Hossein Karami,1 Hadi Darvishi-Khezri,2 Mehrnoush Kosaryan,1 Rosetta Akbarzadeh,2 Mojdeh Dabirian3 1Department of Pediatrics, Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran; 2Stude
Externí odkaz:
https://doaj.org/article/4e318aaf27f84c0183ab8957e1e262e7
Autor:
Darvishi-Khezri H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Karami H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Naderisorki M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Ghazaiean M; Gut and Liver Research Center, Non-communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran., Kosaryan M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Mosanejad-Galchali A; MD. Islamic Azad University, Sari Branch, Mazandaran, Iran., Aliasgharian A; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Karami H; Department of Pediatrics, Mazandaran University of Medical Sciences, Sari, Iran.
Publikováno v:
PloS one [PLoS One] 2024 Jan 12; Vol. 19 (1), pp. e0284267. Date of Electronic Publication: 2024 Jan 12 (Print Publication: 2024).
Publikováno v:
مجله دانشگاه علوم پزشکی گرگان, Vol 17, Iss 4, Pp 106-111 (2015)
Background and Objective: Alpha Thalassemia is one of the most prevalent hemaglobinophaties worldwide. Alpha thalasseima patients may represent wide spectrum of symptoms ranging from asymptomatic to severe life threatening anemia. This study was done
Externí odkaz:
https://doaj.org/article/e8be93da4ebf4154af93eaebd924cdbc
Publikováno v:
مجله دانشگاه علوم پزشکی گرگان, Vol 17, Iss 3, Pp 108-113 (2015)
Background and Objective: The national screening program for G6PD enzyme deficiency is not able to detect all affected neonates. This study was done to compare the fluorescent spot test (FST), decolorization test, and quantitative enzyme assay (QEA)
Externí odkaz:
https://doaj.org/article/731edfa433ff4645b03ef3cd31b2d3fc
Publikováno v:
مجله دانشگاه علوم پزشکی گرگان, Vol 17, Iss 1, Pp 108-113 (2015)
Background and Objective: Hemoglobin D-Punjab is one of the variant of hemoglobin caused by a mutation on position 121 of beta globin gene which is frequent in India, Pakistan and Iran. Heterozygote form of this variant is mainly asymptomatic while i
Externí odkaz:
https://doaj.org/article/32c71a4f4cd44126b1832805b8341b8e
Publikováno v:
مجله دانشگاه علوم پزشکی گرگان, Vol 16, Iss 3, Pp 76-79 (2014)
Background and Objective: Repeated blood transfusion is the major treatment for patients with major thalassemia. However due to antigen encounters, it may initiate body reactions, including alloantibodies against red blood cell antigens. This study w
Externí odkaz:
https://doaj.org/article/43d1361981f74d2f984b3677f6c27dac
Autor:
Karami H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Khalilzadeh Arjmandi H; Student Research Committee, Phamaceutical Science Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Salehifar E; Phamaceutical Science Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Darvishi-Khezri H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Dabirian M; Department of Cardiology, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran., Kosaryan M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Aliasgharian A; Medical Microbiology, Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Akbarzadeh R; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Naeimayi Aali R; Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran., Nasirzadeh A; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Publikováno v:
International journal of clinical practice [Int J Clin Pract] 2021 Aug; Vol. 75 (8), pp. e14337. Date of Electronic Publication: 2021 May 24.
Autor:
Darvishi-Khezri H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Khalilzadeh Arjmandi H; Student Research Committee, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Aliasgharian A; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Shaki F; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran., Zahedi M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.; Student Research Committee, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran., Kosaryan M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Karami H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Naeimayi Aali R; Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran., Salehifar E; Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Publikováno v:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Dec; Vol. 36 (12), pp. e24752. Date of Electronic Publication: 2022 Nov 10.
Autor:
Darvishi-Khezri H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Aliasgharian A; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Naderisorki M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Kosaryan M; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Ghazaiean M; Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran., Fallah H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran., Zahedi M; Department of Medical Biotechnology, Student Research Committee, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran., Karami H; Thalassemia Research Center (TRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran. karami_oncologist@yahoo.com.
Publikováno v:
Scientific reports [Sci Rep] 2022 Oct 26; Vol. 12 (1), pp. 17996. Date of Electronic Publication: 2022 Oct 26.
Publikováno v:
Medicinski Glasnik, Vol 8, Iss 2, Pp 192-196 (2011)
Scopus-Elsevier
Scopus-Elsevier
Aim To investigate the humeral immune markers in patients with ß-thalassemia major (TM). Methods In this historical – cohort study (August to December 2007), the case group consisted of 34 TM patients and the control group included the same number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bd53d587790d1b22e23f3cb4aac54a5c
http://www.ljkzedo.com.ba/medglasnik/vol82/MGvol82.2011_4.pdf
http://www.ljkzedo.com.ba/medglasnik/vol82/MGvol82.2011_4.pdf